KBio
Pre-clinicalKBio uses plants as biofoundries to produce therapeutics and bioactives on an unprecedented scale.
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $62M
About
KBio uses plants as biofoundries to produce therapeutics and bioactives on an unprecedented scale.
AntibodiesBiologics
Funding History
2Total raised:$62M
Series A$50MNov 15, 2023
Seed$12MMay 15, 2022